EP3852714A1 - Composition anti-rides - Google Patents

Composition anti-rides

Info

Publication number
EP3852714A1
EP3852714A1 EP19787083.5A EP19787083A EP3852714A1 EP 3852714 A1 EP3852714 A1 EP 3852714A1 EP 19787083 A EP19787083 A EP 19787083A EP 3852714 A1 EP3852714 A1 EP 3852714A1
Authority
EP
European Patent Office
Prior art keywords
acetyl
composition
extract
formulation
formulation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP19787083.5A
Other languages
German (de)
English (en)
Inventor
Camilla D'ANTONIO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medspa Srl
Original Assignee
Medspa Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medspa Srl filed Critical Medspa Srl
Publication of EP3852714A1 publication Critical patent/EP3852714A1/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18

Definitions

  • the present invention describes a composition comprising acetyl sh-heptapeptide-1 , acetyl hexapeptide-8 , and extract of sea buckthorn (Hippophae rhamnoides L.) kernels.
  • a formulation in the form of a face mask, serum or cream comprising the composition of the invention, and the use of said formulation to achieve one or more of the following cosmetic effects: fleshed skin, hydration, luminosity, regeneration, face oval redesigning, reduction of signs of aging.
  • Figures 1 to 3 show the results related to immediate clinical parameters and long-term instrumental parameters .
  • composition comprising: acetyl sh-heptapeptide-1 , acetyl hexapeptide-8 , and extract of sea buckthorn (Hippophae rhamnoides L.) kernels .
  • said composition can further comprise one or more of the ingredients selected from: hydrogenated lecithin and/or shea butter.
  • a further object of the present invention consists of formulations comprising the above composition, wherein said formulations are in the form of face masks, serum, cream.
  • each of the above mentioned three components: acetyl sh-heptapeptide-1, acetyl hexapeptide-8, and extract of sea buckthorn (Hippophae rhamnoides L.) kernels, hydrogenated lecithin and shea butter, can be included in a formulation of the invention in a percentage between about 0.05 and 12% weight/volume, and preferably between about 2 and 10% weight/volume .
  • said formulation comprises:
  • said formulation comprises :
  • the formulations of the invention further comprise one or more of the excipients selected from: consistency factors, emulsifiers, preservatives, oils and fat phase, perfumes or essences, water.
  • said excipients are included in an amount as follows:
  • the excipients are selected from the group comprising: glycerin, glyceryl polyacrylate, ethyl hexyl glycerin, butylene glycol, propyl heptyl caprylate, propylene glycol, phenoxyethanol , chlorphenesin, methyl parabens, sodium polyacrylate, maltodextrins , sodium diphosphate, sodium phosphate, caprylyl glycol, EDTA, disodium EDTA, cetearyl alcohol, glyceryl stearate, peg 100 stearate, biosaccharide gum-1 ethylhexyl palmitate, tocopheryl acetate, xylitol, ceramide 3, ceramide 6 II, ceramide 1, phytosphingosine, cholesterol, sodium lauroyl lactylate, carbomer, xanthan gum, octadecene dioic acid, sodium h
  • a formulation in the form of a face mask is described .
  • said "face mask” formulation can comprise further components selected from the group comprising: clay, kaolin, cucumber, birch extract, green tea, witch hazel, burdock, sage and tea tree oil, amylaceous substances, pectins, dog rose extract, antioxidants, hyaluronic acid, collagen, alpha-hydroxy acids such as mandelic acid, glycolic acid, citric acid, tartaric acid, beta-hydroxy acids, such as salicylic acid, oil of Argania spinosa kernel, oil of Gossypium herbaceum seeds.
  • said formulation is a day or night face cream or is a serum.
  • said "face cream” and/or “serum” formulations comprise further active ingredients selected from the group comprising: glycolic acid, hyaluronic acid, kojic acid, salicylic acid, alpha hydroxy acids (AHA), antioxidants such as for example: vitamin A, vitamin C, vitamin E, alpha-lipoic acid, coenzyme Q10, ferulic acid, phloretin, citric acid, ceramides, silicone derivatives, green tea extract, hydroquinone, beta hydroxy acids (Bhas), peptides, copper peptides, retinoids.
  • active ingredients selected from the group comprising: glycolic acid, hyaluronic acid, kojic acid, salicylic acid, alpha hydroxy acids (AHA), antioxidants such as for example: vitamin A, vitamin C, vitamin E, alpha-lipoic acid, coenzyme Q10, ferulic acid, phloretin, citric acid, ceramides, silicone derivatives, green tea extract,
  • compositions and formulations for the treatment of skin aging described the use of the composition and formulations for the treatment of skin aging.
  • such a treatment is a cosmetic treatment.
  • composition according to the present invention is for use in a cosmetic method in order to achieve one or more of the following cosmetic effects: fleshed skin, hydration, luminosity, regeneration, face oval redesigning, reduction of signs of aging.
  • composition according to the present invention has been shown to have both a short- and a long-term effect in reducing wrinkle visibility.
  • the tested composition comprises acetyl sh-heptapeptide- 1, acetyl hexapeptide-8 and extract of sea buckthorn (Hippophae rhamnoides L.) kernels.
  • the eye contour wrinkle volume was instrumentally evaluated after 21 and 42 days of use.
  • Treatment method the composition was applied overnight in a monolayer on the face and eye contour and left on for 20 minutes. A massage was then performed to spread well the residue, without a final rinse. During the day, the volunteers applied a SPF50+ protection.
  • Instrument parameters at time [to] (basal value) and after prolonged use of the product: after 21 days [t 2i ] , after 42 days [ t 4 2 ] , measurements of wrinkle volume were performed. Data are studied with Antera 3D® and processed with Antera 3D® software. Antera 3D® is a camera capturing high-resolution images. The instrument is able to acquire three-dimension images so as to obtain parameters related to expression lines, wrinkles and furrows (skin characteristics which are hollow with respect to the normal skin surface) . Measurements of the volume of a wrinkle are expressed in mm 3 .
  • the established acceptability threshold is 5%.
  • the "wrinkle visibility" parameter was analyzed according to the following criteria:
  • the Table in Figure 2 shows data referred to the eye contour wrinkles, the visibility of which is reduced, even if not statistically significantly reduced, in 25% of the volunteers immediately after the use of the product .
  • Wrinkle volume is reduced by 8% after 21 days of use of the product (not statistically significant) , and statistically significantly by 17% after 42 days of use of the product. Data are shown in the Table in Figure 3. Self-evaluations
  • composition according to the present invention In order to show the synergic effect achieved by the composition according to the present invention, the following parameters were evaluated in a comparative test, on a homogeneous sample of subjects.
  • the observed parameters were: fleshed skin, hydration, luminosity, regeneration, face oval redesigning, reduction of signs of aging.
  • the tested compositions are:
  • the treatment was carried out for 56 days, with applications repeated twice a day.
  • the same team monitored the 4 treatment groups.
  • composition A is capable of generating a "fleshed skin” effect, not occurring with any one of the other compositions tested for comparative purposes.
  • the composition according to the present invention leads to a marked effect of face oval redesigning and reduction of signs of aging.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

La présente invention concerne une composition comprenant de l'acétyl-sh-heptapeptide-1, de l'acétyl hexapeptide-8 et un extrait de graines d'argousier (Hippophae rhamnoides L.). La présente invention concerne en outre une formulation sous la forme d'un masque facial, d'un sérum ou d'une crème comprenant la composition de la présente invention et l'utilisation de ladite formulation pour lutter contre les effets de vieillissement du visage.
EP19787083.5A 2018-09-20 2019-09-20 Composition anti-rides Pending EP3852714A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT201800008773 2018-09-20
PCT/IB2019/057965 WO2020058923A1 (fr) 2018-09-20 2019-09-20 Composition anti-rides

Publications (1)

Publication Number Publication Date
EP3852714A1 true EP3852714A1 (fr) 2021-07-28

Family

ID=64557066

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19787083.5A Pending EP3852714A1 (fr) 2018-09-20 2019-09-20 Composition anti-rides

Country Status (2)

Country Link
EP (1) EP3852714A1 (fr)
WO (1) WO2020058923A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115364015A (zh) * 2022-09-23 2022-11-22 广州品尚生物科技发展有限公司 一种抗皱霜及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2943255B1 (fr) * 2009-03-17 2012-02-24 Rocher Yves Biolog Vegetale Utilisation cosmetique d'un extrait d'hippophae
KR101276141B1 (ko) * 2011-06-13 2013-06-18 동국대학교 산학협력단 갈매보리수나무 씨앗 추출물 및 이의 제조방법
US20160243023A1 (en) * 2015-02-19 2016-08-25 Elc Management Llc Novel Skin Remodeling Strategy

Also Published As

Publication number Publication date
WO2020058923A1 (fr) 2020-03-26

Similar Documents

Publication Publication Date Title
JP6968534B2 (ja) ピキア・アノマーラ及びチコリ根抽出物を含む局所用組成物
CA2552607C (fr) Composition cosmetique et procede pour retarder la croissance des cheveux
EP2763648B1 (fr) Compositions de soin des cheveux et procédés d'utilisation
TW457094B (en) Topical composition for enhancing lipid barrier synthesis
US20100247692A1 (en) Cholesterol Sulfate And Amino Sugar Compositions For Enhancement Of Stratum Corneum Function
JP2008195734A (ja) 皮膚加齢の徴候を処置するための組成物
US9554979B2 (en) Hair care compositions and methods of use
US20190125657A1 (en) Cosmetic use of khaya senegalensis extract
CN113260423A (zh) 促进体内最优皮肤白脂肪组织组合物的局部施用组合物和方法
US20240148632A1 (en) Topical compositions containing n-acyl dipeptide derivatives and glycolic acid
EP3852714A1 (fr) Composition anti-rides
JP2005047910A (ja) 皮脂分泌抑制用組成物
EP0779069A1 (fr) Activateur de cellule mere de cheveux et procede d'activation de cellule mere de cheveux
US20170020805A1 (en) Cordyceps containing topical skin care formulation
FR3061015B1 (fr) Utilisation cosmetique d'un extrait de corchorus olitorius
WO2017204365A1 (fr) Améliorant de structure lamellaire et améliorant de rétention d'humidité
EP3102178B1 (fr) Nouvelle utilisation de composés de parfumerie contre la repousse de poils
WO2024056566A1 (fr) Utilisation d'une composition de thioéthylamine pour le rajeunissement de la peau et effet synergique amélioré lorsqu' elle est combinée à un acide organique et/ou à de l'azabenzène-4-carboxamide
FR3101545A1 (fr) Utilisation cosmétique ou nutraceutique d’un extrait deTerminalia catappa
US20180289612A1 (en) Cosmeceutical
PL241736B1 (pl) Kompozycja kosmetyczna zapobiegająca wypadaniu włosów i stymulująca ich wzrost
KR20150087138A (ko) 피부 개선용 조성물

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210305

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

RAV Requested validation state of the european patent: fee paid

Extension state: TN

Effective date: 20210305

Extension state: MA

Effective date: 20210305